Gene · 100302148
MIR1263: microRNA 1263
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. MIR1263: microRNA 1263. Genes, record 100302148. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/100302148
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants475
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MIR1263 papers | Newest fiscal year |
|---|---|---|---|
| P30AG028740 | University of Florida Older Americans Independence Center (OAIC) | 4 | 2025 |
| P01HL116263 | HDL Function in Human Disease | 3 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 3 | 2025 |
| U54GM104940 | Louisiana Clinical and Translational Science Center | 3 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 2 | 2025 |
| P30ES009089 | Center for Environmental Health in Northern Manhattan | 2 | 2025 |
| R01ES034542 | Functional Genomics of LINE-1 Retrotransposition | 2 | 2025 |
| T32GM008721 | Molecular Biology in Burns and Trauma | 2 | 2025 |
| UL1TR002378 | Georgia Clinical & Translational Science Alliance (Georgia CTSA) | 2 | 2025 |
| F30EY033642 | microRNA-204 and microRNA-211 regulation of RPE phagocytosis | 1 | 2025 |
1 to 10 of 475Source NIH's project files
See all 475 nih grantsPapers1,578
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Investigation of the relationship between expression patterns of plasma microRNAs and pregnancy complications. | Rev Assoc Med Bras (1992) | 2026 | 42820576 | PubTator, text mining | PubMed |
| AKT Inhibitor Capivasertib as a Target for Osimertinib Combination Therapy in Lung Adenocarcinoma with EGFR Mutation. | Genes (Basel) | 2026 | 42792909 | PubTator, text mining | PubMed |
| Systematic review and meta-analysis of circulating microRNAs in dengue infection: biomarkers, pathogenesis, and clinical implications. | Funct Integr Genomics | 2026 | 42645575 | PubTator, text mining | PubMed |
| Prioritizing extracellular miRNA candidates in asthma: transparent in silico integration, literature-based concordance, and mechanistic network analysis. | Front Allergy | 2026 | 42620810 | PubTator, text mining | PubMed |
| Asthma Exacerbations: Integrative Analysis of miRNA Activity Using Single-Cell Transcriptomics. | bioRxiv | 2026 | 42620245 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Cardiovascular Disease: Intercellular Signaling, Liquid Biopsy Biomarkers, and Therapeutic Translation. | Circ Res | 2026 | 42594169 | PubTator, text mining | PubMed |
| Integrated Epidemiological and Extracellular Vesicle Profiling Identifies miR-126-3p, miR-21-5p, miR-92a-3p and SNAIL as Candidate Biomarkers of Endothelial Dysfunction and Cardio-Metabolic Risk. | Int J Mol Sci | 2026 | 42589621 | PubTator, text mining | PubMed |
| Intra-articular delivery of VEGF targeting miR-126-3p and miR-140-5p ameliorates synovitis and pain in a rat model of post-traumatic knee osteoarthritis. | J Orthop Translat | 2026 | 42564586 | PubTator, text mining | PubMed |
| miRNA-mediated cell-to-cell communications boost DNA repair during the radioadaptive response. | Nucleic Acids Res | 2026 | 42554161 | PubTator, text mining | PubMed |
| MiR-126-3p promotes the development and progression of preeclampsia through the inactivation of the PI3K/AKT pathway. | Mol Biol Rep | 2026 | 42484717 | PubTator, text mining | PubMed |
1 to 10 of 1,578
See all 1,578 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/100302148
GET https://conductscience.org/api/genes/v1/100302148/grants?page=2